Skip to content
Recursion Pharmaceuticals Inc icon

Recursion Pharmaceuticals Inc

RXRXStocksBiotechnologyUnited StatesNasdaqUSD

Price

$3.73

Today

+0.8%

YTD

-9.2%

About

Recursion Pharmaceuticals Inc - Class A is a pioneering digital biology company that leverages AI to decode biology and redefine drug discovery. The company operates primarily within the US with its biotech advancements having a global influence. Operating in the biotechnology sector, Recursion Pharmaceuticals merges biology with AI to develop potential treatments for numerous diseases. Although an independent entity, Recursion Pharmaceuticals is also part of a larger community of biotechnology firms reshaping medical science. Stay up to date on the share price of RXRX by adding it to your eToro watchlist.

Price chart
Closing price history for RXRX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.96
P/S (TTM)28.37
P/B (TTM)1.84
Market cap$1.89B
Cap tierSmall-cap
Industry avg P/E-6.22

Profitability

Gross margin-69.58%
EBIT margin-881.32%
Net margin-1815.57%
ROE-57.16%
ROA-42.33%

Earnings & Revenue

Revenue (TTM)$66.41M
Revenue growth (1Y)+11.1%
EPS (TTM)-$1.20
Free cash flow$-325.85M
Total debt$72.38M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.79
Employees600
Next earnings4 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Recursion Pharmaceuticals Inc (RXRX) | Dirk Kuyken